Patents by Inventor Max S. Topp

Max S. Topp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cross Protective Epitopes of Aspergillus Fumigatus and Candida Albicans
    Publication number: 20130315920
    Abstract: A complex comprising a Class II HLA-DRB1*03 or Class II HLA-DRB1*13 molecule bound to a peptide, wherein the peptide comprises the amino acid sequence HTYTIDWTKDAVTWS or a portion thereof, or a variant of the given amino acid sequence or portion wherein the side chains of one or two or three or four or five or six or seven of the amino acid residues are altered, wherein the peptide comprising the portion, or variant, is capable of binding HLA-DRB1*03 and/or HLA-DRB1*13. The complex may be used to select Aspergillus and Candida antigen-specific T cells.
    Type: Application
    Filed: November 16, 2011
    Publication date: November 28, 2013
    Applicant: Cell Medica Limited
    Inventors: Max S. Topp, Claudia Stuehler, Nina Khanna